The DNA Replication Group focuses on the molecular mechanisms underlying genome duplication in normal and tumoural cells. We are interested in the cellular responses to replication stress, a phenomenon known to induce genomic instability. As part of this effort, in the past year, we investigated how cells avoid the accumulation of over-replicated DNA, one of the causes of abnormal gene amplification in tumour cells. We also described the molecular adaptations of the replisome that take place in early embryonic stem cells during pluripotency transitions. Changes in DNA replication dynamics are required for efficient cell reprogramming, which is a promising tool in regenerative medicine. In addition, we reported the biochemical limitations of high-throughput screenings designed to identify SARS-CoV-2 RNA polymerase inhibitors and continued to characterise the role of primase-polymerase PRIMPOL in the replicative tolerance of damaged DNA.

Investigadores Científicos
- Estrella Guarino
- Susana Llanos
- Sara Rodríguez
Becarios Post-doctorales
- Sergio Muñoz
Becarios Pre-Doctorales
- Miguel Curto
- Roberto Masdemont
- Sergi Roig
- Carmen San Martín
Publicaciones recientes
- (2024). RAD51 restricts DNA over-replication from re-activated origins. EMBO J 43, 1043-1064. Publicación CNIO.
- (2024). SIN3A histone deacetylase action counteracts MUS81 to promote stalled fork stability. Cell Reports 43, 113778. Publicación CNIO.
- (2024). A rewiring of DNA replication mediated by MRE11 exonuclease underlies primed-to-naive cell de-differentiation. Cell Reports 43, 114024. Publicación CNIO.
- (2024). Interference of small compounds and Mg2+ with dsRNA-binding fluorophores compromises the identification of SARS-CoV-2 RdRp inhibitors. Sci Rep 14, 28250. Publicación CNIO.
- (2024). PARP1, DIDO3, and DHX9 Proteins Mutually Interact in Mouse Fibroblasts, with Effects on DNA Replication Dynamics, Senescence, and Oncogenic Transformation. Cells 13, 159. Publicación CNIO.
- (2023). RHOJ controls EMT-associated resistance to chemotherapy. Nature 616, 168-175. Publicación CNIO.
- (2023). miR-28-based combination therapy impairs aggressive B cell lymphoma growth by rewiring DNA replication. Cell Death Dis 14, 687. Publicación CNIO.
- (2022). Stress-triggered hematopoietic stem cell proliferation relies on PrimPol-mediated repriming. Mol Cell 38, 4176-4188. Publicación CNIO.
- (2022). 3D chromatin connectivity underlies replication origin efficiency in mouse embryonic stem cells. Nucleic Acids Res 50, 12149-12165. Publicación CNIO.
Open Access - (2022). A truncating variant of RAD51B associated with primary ovarian insufficiency provides insights into its meiotic and somatic functions. Cell Death Differ 29, 2347-2361. Publicación CNIO.
- (2022). Regulation of Claspin by the p38 stress-activated protein kinase protects cells from DNA damage. Cell Reports 40, 111375. Publicación CNIO.
- (2021). Motif WFYY of human PrimPol is crucial to stabilize the incoming 3′-nucleotide during replication fork restart. Nucleic Acids Res 49, 8199-8213. Publicación CNIO.
Open Access - (2021). PrimPol-mediated repriming facilitates replication traverse of DNA interstrand crosslinks. EMBO J 40, e106355. Publicación CNIO.
